About Oxsed
Oxsed is a company based in United Kingdom founded in 2020 by Zhanfeng Cui was acquired by Prenetics in October 2020. The company has 9 employees as of December 31, 2021. Oxsed operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter United Kingdom
- Employees 9 as on 31 Dec, 2021
- Founders Zhanfeng Cui
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Oxsed Limited
- Date of Incorporation 13 May, 2020
- Jurisdiction BOLTON, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oxsed
Investments & Acquisitions by Oxsed
Financial Statements - Oxsed
Oxsed Comparisons
Competitors of Oxsed
Oxsed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Food safety technologies are provided for pathogen identification.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Cloud-powered POC MDx device
|
Frequently Asked Questions about Oxsed
Oxsed was founded in 2020.
Oxsed is headquartered in United Kingdom.
As of Dec 31, 2021, the latest employee count at Oxsed is 9.
Oxsed was founded in 2020 in the United Kingdom within the diagnostics sector. A flagship rapid diagnostic assay, the Oxsed RaViD Direct SARS-CoV-2 Test, is offered for detecting SARS-CoV-2 infections. Nasopharyngeal swabs, saliva, and mouthwash specimens are utilized as samples. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is employed to identify viral RNA through nucleic acid amplification testing (NAAT). Operations focus on point-of-care testing for respiratory infections.
Oxsed's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Oxsed has 1 investor. Key investors include Prenetics.